January 31, 2019 / 10:59 PM / 3 months ago

BRIEF-Roche Diagnostics Says Receives Health Canada Authorization To Market Cobas Hpv On Cobas 6800/8800 Systems For Cervical Cancer Screening In Canada

Jan 31 (Reuters) - Roche Holding AG:

* ROCHE DIAGNOSTICS - RECEIVES HEALTH CANADA AUTHORIZATION TO MARKET COBAS HPV ON COBAS 6800/8800 SYSTEMS FOR CERVICAL CANCER SCREENING IN CANADA. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below